欧普康视 (300595)

AUTEK CHINA INC

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 89528.91
  • Circulating A-Shares(W): 66849.48
  • Earnings Per Share(RMB): 0.4950
  • Net Assets Per Share(RMB): 5.5152
  • Operating Revenue(W RMB): 143279.13
  • Total Profit(W RMB): 57955.00
  • Net Profit Attributable to Parent(W RMB): 44204.96
  • Net Profit Growth Rate(%): -15.41
  • Weighted Return on Equity(%): 9.1300
  • Operating Cash Flow Per Share(RMB): 0.6410
  • Undistributed Profit Per Share(RMB): 2.9180
  • Capital Reserve Per Share(RMB): 1.2508

2. Main Business

The main business covers:

  • Vision care products
  • Vision care services

3. Company Basic Information

  • Company Name: OVCTEK China Inc.
  • Listing Date: 2017-01-17
  • Industry: Medicine & Healthcare - Medical Devices (CSRC Industry: Special Equipment Manufacturing)
  • Address: No. 4899, Wangjiang West Road, High-tech Zone, Hefei City, Anhui Province
  • Website: www.orthok.cn
  • Company Profile: The company's predecessor was OVCTEK Technology (Hefei) Co., Ltd., a wholly foreign-owned enterprise established in September 2000. In November 2013, the company was restructured into a joint-stock company. The company is primarily engaged in vision care products and services.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Nanjing Outao Information Technology Co., Ltd. General Legal Person 10046.44 15.03
2 Hefei Oupu Minsheng Investment Management Partnership (Limited Partnership) General Legal Person 2905.62 4.35
3 ChinaAMC CSI Medical Care ETF Fund 1524.10 2.28
4 E Fund ChiNext ETF Fund 1090.64 1.63
5 CSI 500 ETF Fund 780.83 1.17
6 Hong Kong Securities Clearing Company Ltd. Northbound Capital 655.00 0.98
7 Penghua Pharmaceutical Technology Stock Fund Class A Fund 389.76 0.58

5. Concept Sectors

  • Gene Concept
  • Cross-border E-commerce
  • Internet Celebrity Economy
  • AI Glasses
  • Margin Trading & Securities Lending
  • ChiNext 300
  • ChiNext Quality
  • ChiNext Medicine
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information